Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FANCF | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | ZNF337 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
mRNA | AC092835.2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
mRNA | ZNF559-ZNF177 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
mRNA | TFAP4 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | KANSL1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | POLD1 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | ZNF317 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | RALGDS | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |